Prior work with human brain tissue samples has shown an elevation of isoprenoid biosynthesis in AD brains compared with controls, reflected by an increase in the level of FPP and GGPP and the mRNA expression of FPPS and GGPPS [23, 24]. This evidence concerns the gene GGPS1 and Alzheimer disease.